Overview

A Study of LY2951742 in Healthy Japanese and Caucasian Participants

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety of the study drug known as LY2951742 in healthy Japanese and Caucasians. The study will also investigate how the body processes the drug and how the drug affects the body. The study is expected to last about 5 to 7 months, depending on the arm.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company